Alterations in Monocyte CD16 in Association with Diabetes Complications

Table 1

Demographic and clinical parameters of control and diabetic subjects with or without complications.

	Control	Diabetic	Diabetic
	(𝑛=22)	(𝑛=43)	D^−Comps (𝑛=25)	D^+Comps (𝑛=18)
Age (yrs)	49.7±9.0	62.7±11.7^∗	63.3±8.6	61.8±15.2
Duration (yrs)	n.a.	19.5±7.5	17.8±6.7	21.8±8.1
Weight (kg)	76.3±18.7	79.9±14.1	79.3±14.8	80.7±13.5
BMI (kg/m^2)	28.5±7.8	28.7±4.9	29.1±5.1	28.2±4.7
HbA1c (%)	n.a.	7.5±1.1	7.1±0.6	8.2±1.2^†
Serum creatinine (𝜇mol/L)^#	66.0 (62.3–80.0)	80.0 (70.0–95.0)*	70.0 (63.5–83.5)	89.5 (79.8–103.8)^†
U Alb/Cr ratio (mg/mmol)^#	0.7 (0.6–1.2)	1.5 (0.8–3.0)*	0.9 (0.6–1.5)	3.2 (1.9–8.9)^†
eGFR (mL/min)	91.4±16.9	80.8±24.4	86.6±23.0	72.6±24.6
Triglycerides (mmol/L)	1.2±0.5	1.5±0.8	1.6±0.8	1.5±0.8
HDL cholesterol (mmol/L)	1.8±0.5	1.3±0.4^∗	1.4±0.3	1.2±0.4
LDL cholesterol (mmol/L)	3.0±0.6	2.1±0.7^∗	2.2±0.8	1.9±0.6
Sys BP (mmHg)	116±14	127±16^∗	124±16	132±15
Dias BP (mmHg)	77±8	74±7	74±7	74±7

Results are expressed as mean ± SD, except (^#) shown as median with interquartile range (IQR).
Significantly different if 𝑃<0.05 indicated as (*) for controls versus diabetes and (^†) for D^−Comps versus D^+Comps.